Expression and Clinical Significances of c-erbB-2,bcl-2 and p53 in Colorectal Neoplasms
Jiang Ai-mi
Abstract
Jiang Ai-mi
Abstract
Background:c-erbB-2,bcl-2 and mutation of p53 are mutually interregulated and may play important roles in the carcinomatous changes of colorectal adenoma.Aims:To appraise the protein expression of c-erbB-2,bcl-2 and p53 in colorectal neoplasms and their clinical significances.Methods:Immunohistochemical method was used to detect the protein expression of c-erbB-2,bcl-2 and p53 in 42 colorectal adenocarcinoma,10 adenoma and 10 normal colorectal mucosal tissue.The relationships between these protein expression and the clinicopathologic characteristics of colorectal adenocarcinoma were analyzed.Results:Significant differences could be found among colorectal adenocarcinoma,adenoma and normal colorectal mucosal tissue in the protein expression of c-erbB-2,bcl-2 and p53(P0.05).bcl-2 protein expression in colorectal adenocarcinoma was decreased as compared with that in the adenoma while the protein expression of c-erbB-2 and p53 in colorectal adenocarcinoma was increased.From well-,moderately-to poorly-differentiated adenocarcinoma of colorectum,the protein expression of c-erbB-2 increased and bcl-2 decreased gradually,and protein expression of c-erbB-2 and p53 was positively correlated with lymph node metastasis and Dukes staging of colorectal adenocarcinoma.Negative correlation was found between the protein expression of bcl-2 and p53 in the colorectal adenocarcinoma(rs=-0.301,P0.05).Conclusions:c-erbB-2 is involved in the progression,differentiation and metastasis of colorectal cancer.High expression of p53 and relatively low expression of bcl-2 may be correlated with the occurrence and development of colorectal cancer.Over-expression of bcl-2 may be an early event in the development of colorectal cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background:c-erbB-2,bcl-2 and mutation of p53 are mutually interregulated and may play important roles in the carcinomatous changes of colorectal adenoma.Aims:To appraise the protein expression of c-erbB-2,bcl-2 and p53 in colorectal neoplasms and their clinical significances.Methods:Immunohistochemical method was used to detect the protein expression of c-erbB-2,bcl-2 and p53 in 42 colorectal adenocarcinoma,10 adenoma and 10 normal colorectal mucosal tissue.The relationships between these protein expression and the clinicopathologic characteristics of colorectal adenocarcinoma were analyzed.Results:Significant differences could be found among colorectal adenocarcinoma,adenoma and normal colorectal mucosal tissue in the protein expression of c-erbB-2,bcl-2 and p53(P0.05).bcl-2 protein expression in colorectal adenocarcinoma was decreased as compared with that in the adenoma while the protein expression of c-erbB-2 and p53 in colorectal adenocarcinoma was increased.From well-,moderately-to poorly-differentiated adenocarcinoma of colorectum,the protein expression of c-erbB-2 increased and bcl-2 decreased gradually,and protein expression of c-erbB-2 and p53 was positively correlated with lymph node metastasis and Dukes staging of colorectal adenocarcinoma.Negative correlation was found between the protein expression of bcl-2 and p53 in the colorectal adenocarcinoma(rs=-0.301,P0.05).Conclusions:c-erbB-2 is involved in the progression,differentiation and metastasis of colorectal cancer.High expression of p53 and relatively low expression of bcl-2 may be correlated with the occurrence and development of colorectal cancer.Over-expression of bcl-2 may be an early event in the development of colorectal cancer.
Key concepts: Colorectal cancer, Adenocarcinoma, Colorectal adenoma, Immunohistochemistry, Medicine, Cancer research, Adenoma, Colorectal adenocarcinoma